Allogeneic peripheral blood progenitor cells: current status and future directions.
Increasing use is being made of mobilized peripheral blood as a source of hematopoietic stem and progenitor cells for transplantation. Initially, these efforts were focused on autologous applications. However, many centers are now using cells derived from normal donors mobilized with recombinant hematopoietic growth factors for allogeneic transplantation. This article reviews the key issues associated with the use of these cells for hematologic reconstitution and summarizes important recent developments in the field.
Dreger
P
P
Second Department of Medicine and Bone Marrow Transplantation Unit, University of Kiel, Germany.
Glass
B
B
Uharek
L
L
Schmitz
N
N
D001772:Blood Cell Count; D001773:Blood Cells / Q000637:transplantation*; D001853:Bone Marrow / Q000187:drug effects; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000517:prevention & control; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007937:Leukapheresis; D008212:Lymphocyte Depletion; D013601:T-Lymphocytes; D014184:Transplantation, Homologous
D016179:Granulocyte Colony-Stimulating Factor